The Pfizer/BioNTech vaccine is set to be approved for children aged 5-11 in the United States. Image: REUTERS/Dado Ruvic/File Photo/File Photo
Explore and monitor how COVID-19 is affecting economies, industries and global issues
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
India’s leading COVID-19 last-mile responders
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
The views expressed in this article are those of the author alone and not the World Economic Forum.
More on COVID-19See all
February 2, 2023
February 1, 2023
January 30, 2023
January 25, 2023
January 19, 2023
January 16, 2023